ISO 14971 + AAMI TIR57: The Connection

Part of our Cybersecurity risk management series (AAMI TIR57, ISO 14971, IEC 81001-5-1). For the full overview, start with AAMI TIR57 Risk Management for Medical Devices.

Updated April 15, 2025

Looking for the deep workflow mapping? Our newer reference guide, ISO 14971 vs AAMI TIR57: Hazard Analysis Meets Cybersecurity Risk, contains the side-by-side step mapping, a worked infusion-pump traceability example, the three convergence points (harm vocabulary, severity scale, benefit-risk acceptance), and a downloadable harm-taxonomy template. This blog post sets the context; the guide is the working reference.

In medical device manufacturing, risk management and cybersecurity now sit at the center of every program. This is where ISO 14971 and AAMI TIR57 come in. ISO 14971, a globally recognized standard, sets out a framework for risk management in medical devices, covering all safety aspects across the device lifecycle. AAMI TIR57 sits alongside it and focuses on cybersecurity, a risk that has grown sharply in our connected era.

These two standards pull in the same direction, pushing the industry toward safer, more secure medical technology. This article explains how ISO 14971 and AAMI TIR57 work together to address the risks of building and using medical devices, and how their combined use keeps devices safe and reliable as the technology keeps changing.

Key Takeaways

• ISO 14971 sets the overall risk management process.
• AAMI TIR57 focuses on medical device cybersecurity risks.
• Both standards use a shared risk management methodology.
• TIR57 extends 14971 principles to cyber threats.
• Together, they enhance regulatory compliance.
• They support adapting to new technologies.

Table of Contents

• Key Takeaways
• Understanding of ISO 14971
• Key Elements of ISO 14971
• ISO 14971’s Role in Medical Device Cybersecurity
• How ISO 14971 and AAMI TIR57 Work Together
• ISO 14971 Medical Device Cybersecurity FAQs

Why this matters

The FDA's Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions (Feb 3, 2026 final guidance) made cybersecurity documentation a gating criterion for clearance under Section 524B of the FD&C Act. Reviewers apply this guidance to the ISO 14971 and AAMI TIR57 risk work the same way they apply software lifecycle expectations from IEC 62304 and security risk-management expectations from AAMI TIR57 and ANSI/AAMI SW96:2023.

Gaps in this area are the single most common driver of first-cycle cybersecurity Additional Information (AI) requests. The FDA's FY2024 CDRH performance reports show cybersecurity is among the top deficiency categories cited in 510(k) and PMA AI letters, behind only software documentation and clinical evidence. Treating it as a checklist exercise rather than a design-controlled engineering artifact is what creates the gap.

Understanding of ISO 14971

ISO 14971, titled "Medical devices - Application of risk management to medical devices," is an internationally recognized standard that lays out guidelines for managing the risks tied to medical devices. To see its full scope and impact, let's walk through its main parts:

Scope and Purpose:

• Scope: ISO 14971 applies to all stages of the life cycle of a medical device. It covers the process from initial conception to delivery and includes post-market surveillance.
• Purpose: The primary objective of ISO 14971 is to ensure that manufacturers identify possible hazards associated with medical devices, estimate and evaluate the associated risks, control these risks, and monitor the effectiveness of the controls.

Risk Management Process:

• Analysis: This involves identifying hazards and hazardous situations associated with the medical device.
• Evaluation: After identifying risks, they are evaluated to determine their potential impact, considering both the probability of occurrence and the severity of harm.
• Control: This step involves selecting and implementing measures to mitigate or eliminate risks. It also involves evaluating the effectiveness of these control measures.
• Residual Risk Assessment: Post control measures, the standard requires assessing any residual risk to ensure it is acceptable in the context of the device’s benefits.
• Risk Management Review: Regular reviews of the risk management process ensure that new information about risks is consistently incorporated into the risk analysis.

Documentation and Reporting:

• Risk Management File: ISO 14971 mandates maintaining a risk management file, documenting all risk management process steps. This file serves as an audit trail and is crucial to regulatory submissions.
• Communication: The standard emphasizes the importance of communication regarding risks among all stakeholders, including manufacturers, healthcare professionals, patients, and regulatory bodies.

Integration with Quality Management Systems:

• Synergy with ISO 13485: ISO 14971 is often implemented in conjunction with ISO 13485, which specifies requirements for a quality management system in the medical device industry. Together, they ensure that devices meet both quality and safety standards.

Global Recognition and Harmonization:

• International Acceptance: ISO 14971 is recognized globally, aiding manufacturers in meeting regulatory requirements across different countries and regions.
• Harmonization with Regulations: Many regulatory bodies, including the FDA and the European Union, have harmonized their medical device regulations with the principles in ISO 14971.

Key Elements of ISO 14971

Full Risk Management Process

ISO 14971 lays out a detailed process that covers risk analysis, evaluation, control, and review. The process belongs in the initial design and development of medical devices and continues across their lifecycle.

Adaptability and Flexibility

The standard is designed to be adaptable to various types of medical devices, regardless of their complexity or technological sophistication. This flexibility ensures its applicability across a wide range of devices and scenarios.

Global Recognition and Harmonization

ISO 14971 is widely recognized and accepted internationally. It promotes a unified approach to risk management in the global medical device market.

ISO 14971’s Role in Medical Device Cybersecurity

See also: IEC 80001-1: Enhancing Medical Device Cybersecurity, MDCG 2019-16 & MedTech Cybersecurity, and Medical Device Cybersecurity and ISO 9001.

While ISO 14971 does not explicitly target cybersecurity, its principles apply directly to medical device security. Here is how ISO 14971 supports that work:

Systematic Risk Assessment:

ISO 14971's risk assessment and management methodology fits cybersecurity risks. Identifying potential vulnerabilities in software and hardware components of medical devices falls under risk analysis.

Risk Evaluation and Control

The standard's approach to evaluating and controlling risks applies to cyber threats. That includes assessing the likelihood and potential impact of a cyberattack and putting controls in place to reduce those risks.

Whole-Device View of Safety

In an era where medical devices are increasingly connected, ISO 14971's view of safety needs to span both worlds. It makes sure both the physical and cyber sides of device safety get addressed together.

Complementing Cybersecurity Standards

ISO 14971 forms a foundational framework that complements cybersecurity-specific standards like AAMI TIR57. It provides the basis for a risk management strategy that includes cybersecurity.

Adapting to Technological Advances

As medical devices become more technologically advanced, incorporating elements like AI and IoT, ISO 14971’s role in ensuring secure and safe device operation becomes more critical.

How ISO 14971 and AAMI TIR57 Work Together

ISO 14971 and AAMI TIR57 are both key to medical device security. ISO 14971 sets the groundwork for risk management, and AAMI TIR57 focuses on cybersecurity. Here is an expanded look at how the two standards reinforce each other to harden medical devices against cyber threats:

• Shared foundation in risk management: Both ISO 14971 and AAMI TIR57 use risk management principles. ISO 14971 identifies and reduces risks in medical devices, and AAMI TIR57 focuses on cybersecurity risks. The shared foundation keeps the approach consistent across every risk tied to a device.
• Cybersecurity as a core component of risk management: AAMI TIR57 extends ISO 14971 risk management to cover cybersecurity. It guides manufacturers through identifying, analyzing, evaluating, controlling, and monitoring cyber threats, treating those threats as part of device safety and effectiveness.
• Detailed cybersecurity guidance: AAMI TIR57 gives specific guidance on putting cybersecurity controls in place for medical devices, including threat modeling, vulnerability assessment, and control implementation. That detail goes well beyond what ISO 14971 alone provides.
• Stronger regulatory position: ISO 14971 conformance is often needed for medical device approval. Pairing it with AAMI TIR57's cybersecurity principles strengthens a manufacturer's compliance position and shows regulators like the FDA a single, coherent approach to physical and cyber risk.
• Fit for emerging technologies: As medical devices adopt IoT and AI, the pairing of ISO 14971 and AAMI TIR57 matters more. TIR57's cybersecurity focus keeps the risk management strategies in ISO 14971 current against new technology threats.
• Continuous improvement and monitoring: Both ISO and NIST require continuous monitoring and improvement in cybersecurity. That means adapting controls to the latest threats and feeding the results back into the risk file.

Conclusion

Taken together, ISO 14971 and AAMI TIR57 give medical device manufacturers a single, coherent way to address both physical and cybersecurity risks. They are not separate programs that happen to overlap; they reinforce each other.

ISO 14971 lays the groundwork for risk management, and AAMI TIR57 brings a focused lens to cybersecurity, which keeps growing in importance as devices become more connected. Their pairing reflects how medical device safety has changed: traditional risk management now lives alongside cybersecurity work.

Adopting both ISO 14971 and AAMI TIR57 is more than a nod to industry practice. It is a clear commitment to patient safety in an era when technology and healthcare are tightly linked. Read together, the two standards send a clear message: safety and security have to move forward together.

Need help with medical device security? Contact us.

How Blue Goat approaches this

Blue Goat Cyber's medical device practice is led by engineers with CISSP, OSCP, and prior military red-team backgrounds. We treat cybersecurity documentation as design-controlled engineering output, not a submission template, every artifact (threat model, SBOM, security risk assessment, penetration test, labeling) traces back to a controlled requirement and a verified result.

Our engagements deliver the full Feb 3, 2026 guidance documentation set scoped to the device's risk profile, integrated with the existing IEC 62304 software lifecycle and ISO 14971 risk file. See our medical device cybersecurity services for the full scope. If the FDA raises cybersecurity deficiencies after our submission, we resolve them at no additional cost.

FAQ

What is ISO 14971?

ISO 14971 is an international standard for the application of risk management to medical devices. It provides a structured framework for identifying, evaluating, controlling, and monitoring risks associated with product safety and performance, including certain cybersecurity risks.

How does ISO 14971 apply to medical device cybersecurity?

ISO 14971 guides manufacturers in integrating cybersecurity risks into their overall risk management process. This includes assessing threats like unauthorized access or data breaches and applying controls to reduce those risks to acceptable levels. The February 3, 2026 final guidance on premarket cybersecurity also provides relevant considerations for this process.

Is ISO 14971 required for the FDA or EU regulatory submissions?

While not legally mandated, ISO 14971 is widely recognized by the FDA and the EU as a crucial framework for risk management. Applying ISO 14971 can significantly strengthen your cybersecurity documentation in premarket submissions by demonstrating a systematic risk-based approach.

How is cybersecurity risk different from safety risk in ISO 14971?

Safety risk typically relates to device malfunction or failure that can directly harm a patient. Cybersecurity risk involves intentional threats like hacking or unauthorized access that could indirectly lead to patient harm by compromising device function or data. However, both fall under the broader risk management structure of ISO 14971.

Can ISO 14971 help address software vulnerabilities?

Yes, ISO 14971 requires identifying foreseeable hazards, which include software-related threats. Vulnerabilities like buffer overflows, hardcoded passwords, or weak authentication mechanisms must be evaluated for their potential impact and likelihood as part of the risk management process.

What is the role of a risk management file under ISO 14971?

The risk management file, mandated by ISO 14971, documents all steps of the risk management process. This includes risk analysis, evaluation, control measures, and residual risk assessment. It serves as a critical record for demonstrating compliance during regulatory audits and submissions.

About the author

Christian Espinosa, CISSP, Founder, Blue Goat Cyber. Christian leads a team focused exclusively on medical device cybersecurity for FDA premarket submissions and postmarket compliance. Read more about Christian.